In April 2019, the state launched the tax retention and credit refund, a nationwide tax incentive policy, which aims to promote the innovative development of high-tech industries. This paper examines the impact of the policy on the share price of listed companies by using multiple regression analysis with listed companies in the Chinese medicine sector of the industry classification of Zhongtai Securities from 2015 to 2023. It is found that the policy has a significant positive impact on the stock price, and the market reacts positively; at the same time, there is a significant difference in the impact of the policy on the stock price of different types of pharmaceutical listed companies. The results of the study have certain reference significance for further optimising the collection preference policy.

Shi Yingyin, Xu Xuejun. Impact of the "Value-Added Tax (VAT) Credit Refunds" on the Share Price of Listed Companies in the Pharmaceutical Industry. Academic Journal of Business & Management (2024) Vol. 6, Issue 6: 145-151. https://doi.org/10.25236/AJBM.2024.060622.

[1] Xie Hongtao, Zhang Jianshun, Wang Weidui. VAT Input Retention, Cash Flow Squeeze and Rising Corporate Financing Costs-An Empirical Test Based on 2015 Tax Source Survey Data [J]. Journal of Central University of Finance and Economics, 2019, (09):3-12.

[2] Zhao Keran. The Interpretation of VAT Allowance and Refund Policy and Tax Risk Self-Check [A]. China Construction Accounting Society. Proceedings of the fifteenth (2022) conference of the China Construction Accounting Association[C]. China Construction Accounting Association: China Construction Accounting Association, 2022:7. 

[3] Huang Zhiping. On the Positive Role of VAT Allowance and Refund for Enterprises [J]. Finance and Economics, 2022, (31):147-149.

[4] Guo Hongxia, Deng Zhong. Analysis of positive fiscal policy VAT retention tax rebate policy implementation role and problem suggestions--Taking Xilin Gol League as an example [J]. North Finance, 2022, (08):104-106.